Inter-Firm Inventor Collaboration and Path-Breaking Innovation: Evidence From Inventor Teams Post-Merger
Journal of Financial and Quantitative Analysis · 2023-05 · 58 (3) · 1144-1171
DOI: 10.1017/s0022109022000503 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Financial and Quantitative Analysis, online erschienen am 29.04.2022. Verfasst von Kai Li und 1 weiteren Autor:innen. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Using a large and novel data set over the period of 1976 to 2019 tracking inventors’ career paths following mergers and acquisitions, we show that collaboration between acquirer and target inventors post-merger is associated with more path-breaking patents than those filed by either acquirer or target inventor-only teams. We further show that such collaboration is more important in improving acquirers’ innovation capabilities than hiring target inventors and knowledge spillovers. Finally, we show that recombining tacit knowledge embodied in the human capital of acquirer and target inventors is likely the mechanism. We conclude that inter-firm inventor collaboration is one key means for achieving synergies.
Zitieren
APA
Li, K., & Wang, J. (2023). Inter-Firm Inventor Collaboration and Path-Breaking Innovation: Evidence From Inventor Teams Post-Merger. Journal of Financial and Quantitative Analysis, 58(3), 1144-1171. https://doi.org/10.1017/s0022109022000503
Vancouver
Li K, Wang J. Inter-Firm Inventor Collaboration and Path-Breaking Innovation: Evidence From Inventor Teams Post-Merger. Journal of Financial and Quantitative Analysis. 2023;58(3):1144-1171. doi:10.1017/s0022109022000503
BibTeX
@article{Li2023,
author = {Li, Kai and Wang, Jin},
title = {Inter-Firm Inventor Collaboration and Path-Breaking Innovation: Evidence From Inventor Teams Post-Merger},
journal = {Journal of Financial and Quantitative Analysis},
year = {2023},
volume = {58},
number = {3},
pages = {1144--1171},
doi = {10.1017/s0022109022000503}
}
EUVIMED